+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Gilles De La Tourette's Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Gilles De La Tourette's Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Chronic Hand Eczema - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Hand Eczema - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hemophilia A -Pipeline Insight, 2025 - Product Thumbnail Image

Hemophilia A -Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
MTORC1 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

MTORC1 Protein Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenovirus Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Adenovirus Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Neutropenia - Pipeline Insight, 2025 - Product Thumbnail Image

Neutropenia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Atherosclerosis - Pipeline Insight, 2025 - Product Thumbnail Image

Atherosclerosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Achromatopsia - Pipeline Insight, 2025 - Product Thumbnail Image

Achromatopsia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Rotavirus Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Rotavirus Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 220 Pages
  • Global
From
Herpes Zoster - Pipeline Insight, 2025 - Product Thumbnail Image

Herpes Zoster - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 85 Pages
  • Global
From
Fibroblast Growth Factor 2 (FGFR2) - Pipeline Insight, 2025 - Product Thumbnail Image

Fibroblast Growth Factor 2 (FGFR2) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
From
Prosthetic Joint Infections- Pipeline Insight, 2025 - Product Thumbnail Image

Prosthetic Joint Infections- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alpha-1 Antitrypsin Deficiency- Pipeline Insight, 2025 - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Dementia With Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Dementia With Diabetes - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Chronic Pancreatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Pancreatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Bipolar Depression - Pipeline Insight, 2025 - Product Thumbnail Image

Bipolar Depression - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hypofibrinogenemia - Pipeline Insight, 2025 - Product Thumbnail Image

Hypofibrinogenemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Persistent Corneal Epithelial Defects (PCEDs) - Pipeline Insight, 2025 - Product Thumbnail Image

Persistent Corneal Epithelial Defects (PCEDs) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more